AQR Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-409,037
| Closed | -$1.68M | – | 2347 |
|
2022
Q1 | $1.68M | Sell |
409,037
-11,803
| -3% | -$48.4K | ﹤0.01% | 1288 |
|
2021
Q4 | $1.5M | Buy |
420,840
+170,585
| +68% | +$609K | ﹤0.01% | 1348 |
|
2021
Q3 | $911K | Sell |
250,255
-37,112
| -13% | -$135K | ﹤0.01% | 1591 |
|
2021
Q2 | $1.25M | Sell |
287,367
-213,353
| -43% | -$930K | ﹤0.01% | 1477 |
|
2021
Q1 | $2.06M | Sell |
500,720
-188,872
| -27% | -$776K | ﹤0.01% | 1188 |
|
2020
Q4 | $2.75M | Sell |
689,592
-38,976
| -5% | -$155K | ﹤0.01% | 1006 |
|
2020
Q3 | $1.97M | Sell |
728,568
-122,735
| -14% | -$331K | ﹤0.01% | 1111 |
|
2020
Q2 | $2.34M | Buy |
851,303
+754,597
| +780% | +$2.08M | ﹤0.01% | 1088 |
|
2020
Q1 | $228K | Buy |
96,706
+48,995
| +103% | +$116K | ﹤0.01% | 1844 |
|
2019
Q4 | $224K | Sell |
47,711
-19,792
| -29% | -$92.9K | ﹤0.01% | 1982 |
|
2019
Q3 | $226K | Sell |
67,503
-1,790
| -3% | -$5.99K | ﹤0.01% | 1977 |
|
2019
Q2 | $228K | Hold |
69,293
| – | – | ﹤0.01% | 1941 |
|
2019
Q1 | $210K | Buy |
69,293
+16,259
| +31% | +$49.3K | ﹤0.01% | 2061 |
|
2018
Q4 | $144K | Sell |
53,034
-3,478
| -6% | -$9.44K | ﹤0.01% | 2118 |
|
2018
Q3 | $190K | Sell |
56,512
-21,529
| -28% | -$72.4K | ﹤0.01% | 2200 |
|
2018
Q2 | $201K | Sell |
78,041
-35,065
| -31% | -$90.3K | ﹤0.01% | 2222 |
|
2018
Q1 | $249K | Sell |
113,106
-58,733
| -34% | -$129K | ﹤0.01% | 2083 |
|
2017
Q4 | $342K | Buy |
171,839
+24,745
| +17% | +$49.2K | ﹤0.01% | 2028 |
|
2017
Q3 | $477K | Buy |
+147,094
| New | +$477K | ﹤0.01% | 1954 |
|
2014
Q3 | – | Sell |
-27,731
| Closed | -$74K | – | 2616 |
|
2014
Q2 | $74K | Sell |
27,731
-65,900
| -70% | -$176K | ﹤0.01% | 2481 |
|
2014
Q1 | $328K | Hold |
93,631
| – | – | ﹤0.01% | 2226 |
|
2013
Q4 | $419K | Hold |
93,631
| – | – | ﹤0.01% | 2149 |
|
2013
Q3 | $380K | Hold |
93,631
| – | – | ﹤0.01% | 2108 |
|
2013
Q2 | $390K | Buy |
+93,631
| New | +$390K | ﹤0.01% | 1981 |
|